18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism

Part of paid clinical trials in San Francisco, California.

Sponsor
Miguel Pampaloni
Study ID
NCT04205604
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Congenital Hyperinsulinism

Eligibility Criteria

Sex
ALL
Age
0 Days - 18 Years
Healthy Volunteers
Not accepted

Interventions

  • 18F-Fluoro Dopa Imaging — DRUG
    Imaging with 18F-Fluoro Dopa PET Imaging

Study Details

The goal of this project is to determine the role of FDOPA/PET as a pre-operative diagnostic imaging procedure for differentiating focal and diffuse forms of congenital hyperinsulinism and locating focal lesions in the pancreas to guide surgical resection.

Key Dates

Start date
Nov 3, 2016
Status verified
Apr 2026
Primary completion
Dec 1, 2026
Completion
Dec 1, 2026

Study Design

Enrollment
50 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Single Arm,
    Patients with clinically diagnosed congenital hyperinsulinism

Primary Outcome Measure

Sensitivity of Imaging [ Time Frame: four weeks ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of California, San FranciscoSan FranciscoCalifornia94143
Miguel Hernandez Pampaloni, MD, PhD
415-353-1886

Find similar trials in San Francisco, CA

By research site
University of California, San Francisco· San Francisco, CA

Related Studies